CeriBell, Inc. (CBLL)
NASDAQ: CBLL · Real-Time Price · USD
19.50
+0.34 (1.77%)
At close: Mar 17, 2026, 4:00 PM EDT
19.50
0.00 (0.00%)
After-hours: Mar 17, 2026, 4:10 PM EDT

Company Description

CeriBell, Inc. operates as a medical technology company in the United States.

It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting.

The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm.

In addition, it operates an EEG portal, which enables real-time remote access to a patient’s EEG data.

The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015.

CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

CeriBell, Inc.
CeriBell logo
CountryUnited States
Founded2014
IPO DateOct 11, 2024
IndustryMedical Devices
SectorHealthcare
Employees327
CEOXingjuan Chao

Contact Details

Address:
360 North Pastoria Avenue
Sunnyvale, California 94085
United States
Phone800 436 0826
Websiteceribell.com

Stock Details

Ticker SymbolCBLL
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$17.00
CIK Code1861107
CUSIP Number15678C102
ISIN NumberUS15678C1027
Employer ID47-1785452
SIC Code3845

Key Executives

NamePosition
Dr. Xingjuan Chao Ph.D.Co-Founder, President, Chief Executive Officer and Director
Dr. Josef Parvizi M.D., Ph.D.Co-Founder, Chief Medical Advisor and Director
Scott BlumbergChief Financial Officer
Dr. Raymond Woo Ph.D.Chief Technology Officer
Dan RogySenior Vice President of Operations
Louisa Daniels J.D., M.B.A.General Counsel
Brian P. PriceSenior Vice President of Marketing
Kim McKeonVice President of People and Culture
Baharan Kamousi Ph.D.Senior Vice President of Data Science
Sean ManniChief Revenue Officer

Latest SEC Filings

DateTypeTitle
Mar 3, 2026144Filing
Mar 3, 2026144Filing
Mar 3, 2026144Filing
Mar 2, 2026144Filing
Feb 24, 2026S-8Securities to be offered to employees in employee benefit plans
Feb 24, 202610-KAnnual Report
Feb 24, 20268-KCurrent Report
Feb 24, 2026144Filing
Feb 23, 2026144Filing
Feb 23, 2026144Filing